Vitamin B6 (pyridoxine) is one of the hardest-working nutrients in your body. Your level tells you whether you have enough of this vitamin to support the more than 100 enzyme-driven reactions it participates in, including breaking down amino acids, producing brain signaling chemicals, and releasing stored energy from your muscles. If your level is low, these processes slow down, and over time you may develop nerve damage, anemia, or immune dysfunction. If your level is too high from supplementation, paradoxically, the same kind of nerve damage can occur.
This makes vitamin B6 unusual among nutrients: both too little and too much can hurt you, and the window between helpful and harmful is narrower than most people realize. Knowing your level helps you supplement wisely and catch deficiency before symptoms appear.
Several groups face a meaningfully higher risk of deficiency. The most common cause is medication use. Isoniazid (a tuberculosis drug), hydralazine (a blood pressure medication), levodopa/carbidopa (used for Parkinson's disease), and vincristine (a chemotherapy agent) all interfere with vitamin B6 in different ways. Some increase how quickly you excrete it; carbidopa, for instance, irreversibly binds and deactivates the vitamin.
Other medications linked to lower levels include penicillamine, several antiepileptic drugs (carbamazepine, valproate, phenytoin, phenobarbital), gentamicin, and D-cycloserine. If you take any of these, checking your B6 level periodically is a reasonable step.
Beyond medications, certain medical conditions increase your risk:
Here is where vitamin B6 gets counterintuitive. The most common supplement form, pyridoxine, is actually the inactive form. Your body must convert it into PLP, the active form, before it can use it. At high doses, unconverted pyridoxine builds up and competes with PLP for the same enzyme binding sites, effectively blocking the vitamin from doing its job. The result is a functional deficiency created by oversupplementation.
This is why symptoms of B6 toxicity (numbness, tingling, loss of coordination) closely resemble symptoms of B6 deficiency. The damage targets the sensory nerve cell bodies in structures called dorsal root ganglia, and in severe cases, it can be irreversible.
While toxicity is most commonly reported at doses above 2 g per day, nerve damage has been documented with long-term use (more than 6 months) of doses as low as 50 mg per day. The European Food Safety Authority has set the tolerable upper intake level at 12 mg per day for adults. If you need higher doses for a specific condition, PLP-form supplements may carry less neurotoxic risk than pyridoxine, and less frequent dosing (such as weekly rather than daily) is recommended.
What this means for you: if you are taking a B-complex or standalone B6 supplement, check the dose and the form. Many over-the-counter products contain 50 to 100 mg of pyridoxine, which is well above the upper limit set by European regulators. Long-term use at these doses is not without risk.
Your vitamin B6 level responds to both dietary intake and supplementation, and it can be pushed down by medications and medical conditions.
Dietary intake: The recommended daily intake for adults is 1.4 to 1.7 mg per day, with slightly higher needs during pregnancy (1.8 mg/day) and lactation (1.6 to 1.7 mg/day). Rich food sources include poultry, fish, potatoes, chickpeas, bananas, and fortified cereals. For most healthy adults, meeting the recommended intake through diet is sufficient to maintain adequate PLP levels.
Supplementation for documented deficiency: If your level is low due to dietary insufficiency, the standard replacement approach is 50 mg daily for 3 weeks. For deficiency caused by isoniazid, the dose is 100 mg daily for 3 weeks. After repletion, the goal is to maintain your PLP between 30 and 60 nmol/L without overshooting.
Medication interactions: If you take levodopa without carbidopa, you should avoid B6 supplements containing more than 5 mg of pyridoxine, because it counteracts levodopa's therapeutic effect. This interaction does not apply to combination levodopa/carbidopa products. If you take isoniazid, hydralazine, or other depleting medications, prophylactic B6 supplementation may be appropriate, but your level should guide the dose.
Form of supplement: If higher doses are clinically necessary (for example, in rare vitamin B6-responsive neurogenetic conditions requiring up to 600 mg/day), using the PLP form rather than pyridoxine may reduce the risk of neurotoxicity. Doses above 200 mg per day carry significant risk of sensory neuropathy regardless of form.